Revenue of $ 32 billion is expected from vaccines Covid-19 Pfizer for 2022, as its annual profits for 2021 have more than doubled, reaching $ 22 billion.
It also expects sales of $ 22 billion for 2022 from Paxlovid, the company's pill for Covid-19.
The pharmaceutical giant, which with the German company BioNTech received the approval for the first vaccine to fight the deadly virus, recorded in 2021 annual revenues almost double, compared to 2020, at 81,3 billion dollars, with 36,8 billions of dollars to come from the vaccine Covid-19.
The results show how the coronavirus transformed Pfizer, which a year ago had forecast just $ 15 billion in vaccine sales Covid-19 for 2021 and resulted in sales double that amount.
Source: KYPE
An easyJet flight changed course and made an emergency landing in Heraklion due to…
The evidence presented in the court in which 31-year-old Christopher Gregor is being tried is chilling,...
Freedom of the Press is tested all over the planet by illiberal - totalitarian regimes but…
A 25-year-old man from Nicosia was arrested in Larnaca for illegal possession and...
KEPA, in collaboration with the two major sponsors, NEVISO Skirodema and GIOVANI HOMES, having...
"The Personal Envoy of the Secretary General for Cyprus, Maria Angela Holgin, will hold the...